1. We've addressed a number of the issues raised in the previous survey. Please help us make sure we're aware of all issues by completing this new, short, confidential survey. Thank you!
  2. Need help finding a board? Read this post for help

Generi Lyrica!!!! Holy Crap! Is the pain group toast??

Discussion in 'Pfizer' started by Anonymous, Jul 7, 2012 at 1:41 PM.

  1. Anonymous

    Anonymous Guest

    Lupin Pharmaceuticals received FDA approval of its generic Lyrica on July 5. Looks like they may try and challenge the Lyrica patents and launch its generic "at risk" beofre the patents start to expire next year. Anyone have any more knowledge on this? Looks like with Celebrex going generic and Lupin possibly launching a generic Lyrica early, the pain group is history!
     
  2. Anonymous

    Anonymous Guest

    no 2019
     
  3. Anonymous

    Anonymous Guest

    Damn, I thought it went generic in 2018, but it doesn't. It does go generic in 2013. Even though it's for seizures, the criminals in the managed care market and the government will push it for off label everything like they do gabapentin.

    Celebrex goes off patent at the end of 2013 also. http://www.accessdata.fda.gov/scrip...fm?Appl_No=020998&Product_No=001&table1=OB_Rx

    It's for the 100mg. dose but the powers that rule the world will force it on everyone first with 2 pills before any celebrex 200mg brand name sales.

    I think we are truly screwed in Cluster 1. is the Vegas trip a final hurrah for us before the axe falls? Is it their way to deflect the truth and keep us in their game with circus and bread move?

    This truly sucks. I need to sharpen up my resume and start looking, even though I'd rather not.

    Pfizer will lose billions and billions. I will obviously lose my job.
     
  4. Anonymous

    Anonymous Guest

    Oh Lord...as soon as docs know that something is generic they'll switch over. In this territory (south central), managed care coverage of Lyrica is okay but not great. If the generic is available, they will automatically switch because our docs won't do LMNs. The two biggest PBMs in territory are switching most of their fully insured business over to this lame generics plus formulary that pushes all but a few brands out into tier 3 (or 4) and they upped their copays from $60 to $90 on their standard prescription plans.

    Nice.
     
  5. Anonymous

    Anonymous Guest

    If you haven't been looking outside of the industry, your head is in the sand like an ostrich. OF COURSE managed care will force generic down everyone's throats. They (managed care and Pfizer) will save multiple millions of dollars respect by doing so. It shouldn't take a crystal ball to see what could be the future here. As soon as I get a good bite on my resume, I'm out.

    I refuse to be one of those sad sacks lurking around headhunters websites after my job gets hacked, praying for a nibble from some no-name pharmaceutical company in Ohio, or a contract sales company.
     
  6. Anonymous

    Anonymous Guest

    Ha, that means it's covered. No reason you can't max out bonus.

    When showing your CUE slides, just show how excellent our coverage is. Who wouldn't pay 90 for Lyrica?
     
  7. Anonymous

    Anonymous Guest

  8. Anonymous

    Anonymous Guest

    You would have to understand how patents work, and I doubt many at Pfizer have a clue regarding the patenting of pharmaceuticals. Why? Because there is not much of any knowledge from anyone I've seen at Pfizer about anything. Pharma drugs have multiple patents as they get different indications, IV vs. oral doses, or as the molecule is altered during its lifecycle. Those patent expirations can be years apart. This generic approval was based on the patent date that was submitted for that indication.
     
  9. Anonymous

    Anonymous Guest

  10. Anonymous

    Anonymous Guest


    So what patent is expiring?
     
  11. Anonymous

    Anonymous Guest

    I am afraid that this might be a bigger threat to Lyrica than Revatio is to Viagra. This generic will be at the same doses. The doses for seizures are the same w/ just a higher range. I hope we can block this one.
     
  12. Anonymous

    Anonymous Guest

    Lyrica sure did not have a very long life span if you are right. Only launched in 2005
     
  13. Anonymous

    Anonymous Guest

    The patent clock starts ticking when the drug molecule is first submitted before the clinical trials phases, not when the drug gets to market. Seriously, I thought people at Pfizer were the smartest of the smart, the end all-be all. Was that all just smoke and mirrrors all these years.
     
  14. Anonymous

    Anonymous Guest

    I am confused. What is a patent?
     
  15. Anonymous

    Anonymous Guest

    Wow, for an angry Troller you sure are smart. Thanks for posting
     
  16. Anonymous

    Anonymous Guest


    This is important information. Pfizer doesn't want you to know that the first of Lyrica patents start expiring in 2013.
     
  17. Anonymous

    Anonymous Guest

    You, like many of us here, bought into our PR machine. Look, we hit the jackpot 15-20 years ago because of the heavy investment into R&D in the 80s. We also used to hire aggressive, bright junior military officers (many of whom came from West Point), science majors, business majors with very high GPAs from great schools, experienced nurses, and teachers. We could manage our own territories, and we were very aggressive. That aggressiveness and strong portfolio led to other companies begging us to co-promote their drugs.

    Thank GOD for that, because without those drugs Celebrex, Bextra, Zyrtec, Aricept, Lipitor would've gone to someone else, and then we would be selling...uhm, let me think. Back to my story: Peering into the crystal ball in '98 (my start year), we saw that we needed to black widow spider our co-promotes, so we jumped on Warner Lambert for Lipitor sales, and a year or two Pharmacia/Upjohn for COX-2 portfolio, Zyvox (I think?) and their Oncology portfolio, and a bunch of drugs that never made it to market.

    I know that I'm leaving off Spiriva and other meds, but I thank that you catch my point: a lot of our apparent success during our Glory Years was built on our success with Procardia XL, Zoloft, Diflucan, Norvasc, Zithromax, and a few other drugs launched in 1990-1993 (before my time, so I'm guessing). Now that we are reaping the fruits of bad R&D investment ($70 billion in the 90s? OMG!), we are the new Cover Boy of Fortune magazine. The very same magazine that pushed Pfizer on their cover as THE company to work for 18 years ago.
     
  18. Anonymous

    Anonymous Guest

    One more thing: my manager and a Master's in my district told me about how hiring changed, and what it was like before I came. I should've added that in my 1st paragraph.
     
  19. Anonymous

    Anonymous Guest


    The first of the Lyrica patents expires in October 2013. It appears to be for epilepsy but I am not sure. As we all know, indications mean absolutely nothing to managed care. In any case, something smells fishy as to why a generic Lyrica is already approved a year and three months before the first patent expires. Generic firms challenge patents routinely. Look at Celebrex. It is going completely generic in early 2014 yet no news on a generic being approved by the FDA. If Lyrica goes generic (even partially) in 2013 or earlier and Celebrex goes generic in early 2014, it doesn't look good for the pain group.
     
  20. Anonymous

    Anonymous Guest

    How does a drug go "partially generic"? I am a master and have been with pfizer for a long time. never seen that one
     

Share This Page